Reappraisal of Lhermitte's sign in multiple sclerosis

AH Al-Araji, J Oger - Multiple Sclerosis Journal, 2005 - journals.sagepub.com
Lhermitte’s sign (LS) is strongly linked to multiple sclerosis (MS). Our aim is to reassess its
frequency, natural history, various characteristics and neuroradiological correlation in a cohort …

Neuro-Behcet's disease in Iraq: a study of 40 patients

SA Al-Fahad, AH Al-Araji - Journal of the neurological sciences, 1999 - Elsevier
Behcet’s disease (BD) is a chronic, multisystemic disorder with variable prevalence in different
geographical areas. Neurological manifestations (neuro-Behcet’s disease, NBD) are well …

Neuro-Behçet's disease: epidemiology, clinical characteristics, and management

A Al-Araji, DP Kidd - The Lancet Neurology, 2009 - thelancet.com
Behçet's disease (BD) is a multisystem relapsing inflammatory disorder of unknown cause.
In neuro-BD (NBD), the CNS can be involved in one or both of two ways: first, and most …

Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations

…, A Mahr, C Salvarani, PP Sfikakis, A Siva, A Al-Araji - Journal of …, 2014 - Springer
Neuro-Behçet’s disease (NBD) is one of the more serious manifestations of Behçet’s
disease (BD), which is a relapsing inflammatory multisystem disease with an interesting …

Autonomic dysfunction in multiple sclerosis

AH Al-Araji, AM Al-Mahdawi, AI Mohammad - Neurosciences Journal, 2003 - nsj.org.sa
OBJECTIVE: Multiple sclerosis (MS) is a demyelinating disorder of the central nervous
system. Autonomic dysfunction in MS patients may cause significant morbidity. The aim of this …

Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?

A Al-Araji, AI Mohammed - Journal of the neurological sciences, 2005 - Elsevier
OBJECTIVES: To characterize the clinical, demographic and epidemiological features of MS
patients from the only specialised MS centre in Iraq. METHODS: Data for consecutive Iraqi …

Clinical impact of ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19+ B-cell repopulation

…, O Salim, R Abraham, S Kalra, A Al-Araji - Multiple Sclerosis and …, 2021 - Elsevier
In this retrospective clinical audit, 136 patients with MS received Ocrelizumab during the
COVID-19 pandemic. There was no significant difference in clinical relapse rate or radiological …

Ionophore-based potentiometric sensors for the flow-injection determination of promethazine hydrochloride in pharmaceutical formulations and human urine

…, N Ahmad, M Mokhtar, ST Ameen, SM Al-Araji - Sensors, 2011 - mdpi.com
… where h o and h is the peak height for undispersed and dispersed sample, respectively.
The limited dispersion obtained indicate the limited mixing of analyte and solutions in the flow …

The Influence of Age of Onset and Patient's Sex on the Prevalence of Clinical Manifestations of Behcet's Disease in Iraqi Patients

…, Z Al-Rawi, A Hatem, A Al-Araji - Annals of Saudi …, 2002 - annsaudimed.net
Behcet’s disease (BD) is a chronic relapsing disease characterized by multiple signs and
symptoms such as recurrent orogenital ulceration, eye involvement, skin manifestations and …

[PDF][PDF] Multiple sclerosis in Iraq: History, epidemiology and the future

Y Falah, A Al-Araji - TOFIQ Journal of Medical Sciences, 2014 - scholar.archive.org
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS)(1).
It is the most common cause of disability in young adults after trauma (2). MS is known …